Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Nuklearmedizin. Nuclear Medicine
|
February 16, 2019
Christina Nguyen Ngoc, Christian Happel, Amir Sabet, et al.
Clinical Case Reports
|
May 8, 2023
Thyroid papillary cancer elements arising from struma ovarii with benign peritoneal strumosis: Utility of iodine-123 imaging in diagnostics and treatment planning
Daniel Groener, Justus Baumgarten, Christian Happel, et al.
Plos One
|
November 19, 2013
High calcium bioglass enhances differentiation and survival of endothelial progenitor cells, inducing early vascularization in critical size bone defects
Karam Eldesoqi, Caroline Seebach, Christina Nguyen Ngoc, et al.
Nuklearmedizin. Nuclear Medicine
|
February 16, 2022
[Anticipating Criteria for Discharge after Lu-177-PSMA Treatment - Discussion of Several Scenarios]
Wolfgang Tilman Kranert, Benjamin Bockisch, Jennifer Wichert, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 26, 2023
Extended therapy with [<sup>177</sup>Lu]Lu-PSMA-617 in responding patients with high-volume metastatic castration-resistant prostate cancer
Nicolai Mader, Christina Nguyen Ngoc, Bilge Kirkgöze, et al.
Cancers
|
August 27, 2021
Salvage Radioligand Therapy with Repeated Cycles of <sup>177</sup>Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer with Diffuse Bone Marrow Involvement
Daniel Groener, Justus Baumgarten, Sebastian Haefele, et al.
Cancers
|
January 21, 2023
Baseline [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT before [<sup>177</sup>Lu]Lu-PSMA-617 Radioligand Therapy: Value of PSMA-Uptake Thresholds in Predicting Targetable Lesions
Daniel Groener, Sina Schneider, Justus Baumgarten, et al.
Cancers
|
February 15, 2022
Safety and Efficacy of <sup>177</sup>Lutetium-PSMA-617 Radioligand Therapy Shortly after Failing <sup>223</sup>Radium-Dichloride
Justus Baumgarten, Daniel Groener, Christina Nguyen Ngoc, et al.
Cancers
|
August 12, 2023
Impact of [<sup>177</sup>Lu]Lu-PSMA-617 Radioligand Therapy on Reference Organ Uptake Assessed by [<sup>68</sup>Ga]Ga-PSMA-11-PET/CT
Daniel Groener, Jennifer Wichert, Magdalena Adams, et al.
EJNMMI Research
|
July 3, 2021
Hematologic safety of <sup>177</sup>Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancer
Daniel Groener, Cam Tu Nguyen, Justus Baumgarten, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Nuklearmedizin. Nuclear Medicine
|
February 16, 2019
Christina Nguyen Ngoc, Christian Happel, Amir Sabet, et al.
Clinical Case Reports
|
May 8, 2023
Thyroid papillary cancer elements arising from struma ovarii with benign peritoneal strumosis: Utility of iodine-123 imaging in diagnostics and treatment planning
Daniel Groener, Justus Baumgarten, Christian Happel, et al.
Plos One
|
November 19, 2013
High calcium bioglass enhances differentiation and survival of endothelial progenitor cells, inducing early vascularization in critical size bone defects
Karam Eldesoqi, Caroline Seebach, Christina Nguyen Ngoc, et al.
Nuklearmedizin. Nuclear Medicine
|
February 16, 2022
[Anticipating Criteria for Discharge after Lu-177-PSMA Treatment - Discussion of Several Scenarios]
Wolfgang Tilman Kranert, Benjamin Bockisch, Jennifer Wichert, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 26, 2023
Extended therapy with [<sup>177</sup>Lu]Lu-PSMA-617 in responding patients with high-volume metastatic castration-resistant prostate cancer
Nicolai Mader, Christina Nguyen Ngoc, Bilge Kirkgöze, et al.
Cancers
|
August 27, 2021
Salvage Radioligand Therapy with Repeated Cycles of <sup>177</sup>Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer with Diffuse Bone Marrow Involvement
Daniel Groener, Justus Baumgarten, Sebastian Haefele, et al.
Cancers
|
January 21, 2023
Baseline [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT before [<sup>177</sup>Lu]Lu-PSMA-617 Radioligand Therapy: Value of PSMA-Uptake Thresholds in Predicting Targetable Lesions
Daniel Groener, Sina Schneider, Justus Baumgarten, et al.
Cancers
|
February 15, 2022
Safety and Efficacy of <sup>177</sup>Lutetium-PSMA-617 Radioligand Therapy Shortly after Failing <sup>223</sup>Radium-Dichloride
Justus Baumgarten, Daniel Groener, Christina Nguyen Ngoc, et al.
Cancers
|
August 12, 2023
Impact of [<sup>177</sup>Lu]Lu-PSMA-617 Radioligand Therapy on Reference Organ Uptake Assessed by [<sup>68</sup>Ga]Ga-PSMA-11-PET/CT
Daniel Groener, Jennifer Wichert, Magdalena Adams, et al.
EJNMMI Research
|
July 3, 2021
Hematologic safety of <sup>177</sup>Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancer
Daniel Groener, Cam Tu Nguyen, Justus Baumgarten, et al.
Page
of 1